NEW YORK, Jan 19 (Reuters) - Mannkind Corp:
* Drops 47.1 percent in extended trade after company says FDA rejects diabetes
device
(Wall Street Newsdesk Telephone: +1 646-223-6110) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Drops 47.1 percent in extended trade after company says FDA rejects diabetes
device
(Wall Street Newsdesk Telephone: +1 646-223-6110) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.